USPTO serial 79433858
PROTEOLUTIONS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- O'BRIEN, JENNIFER LYNN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with PROTEOLUTIONS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological preparations for use in industry and science; nucleic recombinant acids, other than for medical use or veterinary purposes; Nucleic acid sequences, namely, codon-optimized DNA sequences for protein expression, other than for medical use or veterinary purposes; Nucleic acid sequences, namely, codon-optimized DNA sequences for universal protein expression in a variety of production organisms, other than for medical use or veterinary purposes; Protein in raw material form for scientific and medical research and protein for industrial use, namely, recombinant proteins, protein sequences, for use in industry, science, in particular, in silico designed binding proteins; Nucleic acids, other than for medical or veterinary purposes, namely, nucleic acid sequencing programs. | ACTIVE | — |
| 005 | Medical and veterinary preparations, namely, biological and biochemical reagents for medical or veterinary purposes, and diagnostic agents, preparations and substances for medical and veterinary purposes; nucleic recombinant acids and nucleic recombinant sequences, for medical use; biological and biochemical reagents for medical or veterinary purposes, namely, recombinant proteins and protein sequences, for medical use, especially, in silico designed protein agents; biological and biochemical reagents for medical or veterinary purposes, namely, codon-optimized DNA sequences for protein expression, for medical use. | ACTIVE | — |
| 009 | Recorded content, namely, recorded computer programs for codon optimization of DNA sequences for protein expression and in silico design of binding proteins and protein agents, and electronic data files and databases recorded on computer media in the field of codon optimized DNA sequences for protein expression; downloadable software, including downloadable application software, system and system support software and firmware, web applications and server software, artificial intelligence software and machine learning software for codon optimization of DNA sequences for protein expression and in silico design of binding proteins and protein agents; computer interfaces and recorded application programming interface (API) software for the automated codon optimization of DNA sequences for protein expression and in silico design of binding proteins and protein agents | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research, analysis and product development in the field of codon-optimized DNA sequences for protein expression, binding proteins and protein-based agents, providing codon-optimized DNA sequence technology research information for protein expression and product research and design relating thereto; DNA screening and optimization for scientific research purposes, all of the above for use in industry, especially, the creation of codon-optimized DNA sequences for protein expression and the creation of codon-optimized DNA sequences for universal protein expression in a variety of production organisms; computer aided design services, in relation to binding proteins, protein-based agents; consultancy and information in relation to the aforesaid services, included in this class. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Proteolutions UG (haftungsbeschränkt)
- Other trademarks owned by Proteolutions UG (haftungsbeschränkt)
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named PROTEOLUTIONS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 21, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 21, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 15, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 25, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 24, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 24, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 24, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 24, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 1, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 1, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 1, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 1, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 17, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 17, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 5, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 6, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 5, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 30, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 3, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 3, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 2, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |